Preterm neonates benefit from low prophylactic platelet transfusion threshold despite varying risk of bleeding or death

The Platelets for Neonatal Thrombocytopenia (PlaNeT-2) trial reported an unexpected overall benefit of a prophylactic platelet transfusion threshold of 25 × 10(9)/L compared with 50 × 10(9)/L for major bleeding and/or mortality in preterm neonates (7% absolute-risk reduction). However, some neonates...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Blood
Hlavní autoři: Fustolo-Gunnink, Susanna F., Fijnvandraat, Karin, van Klaveren, David, Stanworth, Simon J., Curley, Anna, Onland, Wes, Steyerberg, Ewout W., de Kort, Ellen, d’Haens, Esther J., Hulzebos, Christian V., Huisman, Elise J., de Boode, Willem P., Lopriore, Enrico, van der Bom, Johanna G.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Hematology 2019
Témata:
Clinical Trials and Observations
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6933290/
https://ncbi.nlm.nih.gov/pubmed/31697817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019000899
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky